LAS VEGAS, NV / ACCESSWIRE / August 11, 2014 / Ramoil Management, Ltd (OTC Pink: RAMO) (PINKSHEETS: RAMO), corporate developments and updates are as follows:
PAST: Since our redirection of corporate focus and business model in Q1, 2014, we have successfully signed agreements and made associations with product and equipment suppliers of E-Cigs, LED Lighting and Hydroponics Systems, to support our core business, CBD Extractions, Concentrates and Medicines, now developing and moving forward. Further we have acquired the rights to a "Supercritical CO2 Molecular Extraction Technology" and placed this into our new wholly owned subsidiary "RAMO Bio-Med, Inc.". To compliment this new business model, we signed a market and sales development agreement with "Compliant Collective Consulting, LLC", to aid in the development of marketing and sales channels within California, a 55 Million person market and signed a LOI with "Players Network, Inc.", to begin filming and distributing TV footage of what we do, through their "WEED TV" Network and NextGen TV Enterprises platform, as a way to promote and build our "RAMO" branded products and promote Ramoil Management, Ltd. and RAMO Bio-Med, Inc. to the public and investment community.
PRESENT: As we all know, July and August are historically very slow periods in business, due to many people taking much deserved vacation and family time. However, during this period, we have used this opportunity to continue negotiation on a Joint Venture with "Player’s Network, Inc." on a joint RAMO- Bio-Med (Nevada) extraction facility. All required Nevada licenses, in support of this business activity, have been filed for, deposits and financial guarantees made and awaiting processing and approvals. Further, at this moment, Mr. Goeree, Ramoil Management, Ltd.’s Chairman and CEO, is in Florida, speaking and negotiating with several potential investment groups, interested in similar Joint Venture Extraction Facilities, for Florida. To this end and in support of these efforts, our California Labs have been developing our own High CBD – Low THC Strains of "Charlottes Web", which will be very compliant with all new State and proposed Federal laws and regulations, for the commencement of our next phase and core business of Pharmaceutical Grade CBD Extractions, Concentrates and Medicines.
FUTURE: Now that we have developed the basis of our future core business model and believe we now have the technology and expertise to conduct proper and responsible testing and manufacturing, Ramoil Management, Inc., as the parent corporation, will begin to divide into 2 wholly owned subsidiaries, "RAMO Shops", which will focus on the online and possibly / eventually brick and mortar locations, supply and sales of E-Cigs, LED Lighting and Hydroponics Systems and "RAMO Bio-Med, Inc.", focused on developing our own proprietary strain of High CBD – Low THC "Charlottes Webb" and Extraction Facilities (Labs and Manufacturing), for the development, production and sales of CBD extractions, concentrates and medicines. Updates on this developing market will be posted in Press Releases and on our company website (www.ramocorp.com) over the coming months.
Michael Goeree, the Company’s Chairman, President and Chief Executive Officer, said: "I believe that we are on the right track and in a defined niche sector that will be a multi-billion dollar industry within the coming few years. We now have the technology, the experience and are positioned out in front of this developing market wave and are well readied for success."
About Ramoil Management, Ltd.
Ramoil Management, Ltd. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containing nutraceutical vapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients.
About RAMO Bio-Med, Inc.
RAMO Bio-Med, Inc. is a wholly owned subsidiary of Ramoil Management, Ltd. (RAMO) and is a development stage company. The Company is the operating company of the newly acquired "Supercritical CO2 Molecular Extraction Technology" and will be building operating production facilities and research labs, both domestically and internationally, focused on its own proprietary strain of High CBD – Low THC "Charlottes Webb" and Extraction Facilities (Labs and Manufacturing), for the development, production and sales of CBD extractions, concentrates and medicines.
Forward Looking Statements:
This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
Company and Investor Relations Contact:
Frank Blainey, Esq.
SOURCE Ramoil Management, Ltd.